Biogen Inc. buy Truist Financial Co.
Start price
13.02.25
/
50%
€127.25
Target price
13.02.26
€202.02
Performance (%)
14.30%
Price
14.01.26
€145.45
Summary
This prediction is currently active. The prediction currently has a performance of 14.30%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -9.151% | -9.151% |
| iShares Core DAX® | 0.721% | 4.566% |
| iShares Nasdaq 100 | -0.413% | 1.884% |
| iShares Nikkei 225® | 3.500% | 7.196% |
| iShares S&P 500 | 0.489% | 2.436% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Truist Financial Co. from $220.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat